Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer (Webinar Video Proceedings) | Research To Practice
Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer. Published January 31, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of breast cancer. LEARNING OBJECTIVES Implement a long-term clinical plan for the management of localized hormone receptor (HR)-positive, HER2-negative breast cancer, accounting for newly presented clinical